medigraphic.com

2015, Number 2

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2015; 53 (2)

Management of hyperglycemia in hospitalized patients

Gracia-Ramos AE, Cruz-Dominguez MP, Madrigal-Santillan EO, Morales-González JA, Vera-Lastra OL

Language: Spanish
References: 40
Page: 192-199
PDF size: 141.31 Kb.


ABSTRACT

Diabetes is a global health problem and Mexico rank sixth in prevalence of this entity. In our country, is the leading cause of death and is a major cause of hospital care being responsible for about 1 in 5 discharges. In the hospital setting, it has been observed that hyperglycemia, both diabetic and non-diabetic patients, is associated with an increased risk of complications, disability and death, and that adequate control in the blood glucose level produces a reduction in these complications. With these bases, several associations have recommended the treatment of hospital hyperglycemia through insulin administration, with the therapeutic goal of maintaining a fasting blood glucose level between 100 – 140 mg/dL and glucose at any time of day less than 180 mg/dL. The insulin application method most recommended consisting in a basal-bolus regimen which has shown effi cacy with a low risk of hypoglycemia. The usual practice of the application of insulin through a correction scheme should be abandoned because it is ineffi cient and involves risks.


REFERENCES

  1. Powers AC. Diabetes Mellitus. En: Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J, editores. Harrison: Principios de Medicina Interna. 18a edición. México, Distrito Federal: McGraw-Hill; 2012. p. 2968-3003.

  2. Federación Internacional de Diabetes. Atlas de la Diabetes de la IDFFID[Internet]. 6ª Sexta ed.ición. Brucelas, Bélgica: Federación Internacional de Diabetes; 2013. Disponible en http://www.idf.org/diabetesatlas

  3. Gutiérrez JP, Rivera J, Shamah T, Oropeza C, Hernández Ávila M. Encuesta Nacional de Salud Pública y Nutrición 2012. Resultados Nacionales[Internet]. Primera edición. Cuernavaca, Morelos, México: Instituto Nacional de Salud Pública; 2012. Disponible en http://www.ensanut.insp.mx

  4. Jiméenez-Corona A, Aguilar-Salinas CA, Rojas Martínez R, Hernández-Ávila M. Diabetes mellitus tipo 2 y frecuencia de acciones para su prevención y control. Salud Publica Mex 2013;55 (sSuppl 2):S137-S143. Texto libre en http://www.scielo.org.mx/scielo.php? pid=S0036-36342013000800010&script=sci_arttext

  5. Rull JA, Aguilar-Salinas CA, Rojas R, Ríos-Torres JM, Gómez-Pérez FJ, Olaiz G. Epidemiology of type 2 diabetes in Mexico. Arch Med Res. 2005; 36(3):188–96.

  6. Gutiérrez-Trujillo G, Flores-Huerta S, Fernández- Gárate I, Martínez-Montañez O, Velasco-Murillo V, Fernández-Cantón S, et al. Estrategias de prestación y evaluación de servicios preventivos. Rev Med Inst Mex Seguro Soc. 2006;44(Suppl 1):S3–S21. Texto libre en http://revistamedica.imss.gob.mx/index.php? option=com_multicategories&view=article&id=1231: estrategia-de-prestacion-y-evaluacion-de-serviciospreventivos& Itemid=640

  7. Barquera S, Campos-Nonato I, Aguilar-Salinas C, Lopez-Ridaura R, Arredondo A, Rivera-Dommarco J. Diabetes in Mexico: cost and management of diabetes and its complications and challenges for health policy. Global Health. 2013;9:3. Texto libre en http://www. ncbi.nlm.nih.gov/pmc/articles/PMC3599194/

  8. Vázquez-Martínez JL, Gómez-Dantés H, Fernández- Cantón S. Diabetes mellitus en población adulta del IMSS. Rev Med Inst Mex Seguro Soc 2006;44(1):13-26.

  9. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglucemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87(3):978-982.

  10. Jiang HJ, Stryer D, Friedman B, Andrews R. Multiple hospitalizations for patients with diabetes. Diabetes Care. 2003;26(5):1421-1426.

  11. Gil-Veláazquez LE, Sil-Acosta MJ, Domínguez-Sánchez ER, Torres-Arreola L del P, Medina-Chávez JH. Guía de práctica clínica. Diagnóstico y tratamiento de la diabetes mellitus tipo 2. Rev Med Inst Mex Seguro Soc 2013;51(1):104-119.

  12. Inzucchi SE. Clinical practice. Management of hyperglycemia in the hospital setting. N Engl J Med. 2006;355(18):1903-1911.

  13. Furnary AP, Gao G, Grunkemeier GL, Wu Y, Zerr KJ, Bookin SO, et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2003;125(5):1007-1021.

  14. Van der Berghe G, Wilme A, Hermans G, Meersseman W, Wouters PJ, Milants I, et al. Intensive insulin therapy in the medical UCI. N Engl J Med. 2006;354(5):449-461.

  15. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345(19):1359-1367.

  16. Donner TW, Flammer KM. Diabetes management in the hospital. Med Clin North Am. 2008;92(2):407-425.

  17. Cook CB, Kongable GL, Potter DJ, Abad VJ, Leija DE, Anderson M. Inpatient glucose control: a glycemic survey of 126 U.S. hospitals. J Hosp Med. 2009;4(9):E7-E14.

  18. Membreño-Mann JP, Zonana-Nacach A. Hospitalización de pacientes con diabetes mellitus. Causas, complicaciones y mortalidad. Rev Med Inst Mex Seguro Soc. 2005;43(2):97-101.

  19. McAllister FA, Majumdar SR, Blitz S, Rowe BH, Romney J, Marrie TH. The relation between hyperglycemia and outcomes in 2,471 patients admitted to the hospital with community-adquired pneumonia. Diabetes Care. 2005;28(4):810-815.

  20. Baker EH, Janaway CH, Philips BJ, Brennan AL, Baines DL, Wood DM, Jones PW. Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease. Thorax. 2006;61(4):284- 289. Texto libre en http://www.ncbi.nlm.nih.gov/pmc/ articles/PMC2104606/

  21. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Strees hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke. 2001;32(10):2426-2432. Texto libre en http://stroke.ahajournals.org/content/32/10/2426.long

  22. Kes VB, Solter W, Supanc V, Demarin V. Impact of hyperglycemia on ischemic stroke mortality in diabetic and non-diabetic patients. Ann Saudi Med. 2007;27(5):352-355.

  23. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000;355(9206):773-778.

  24. Angeli F, Verdecchia P, Karthikeyan G, Mazzota G, Del Pínto M, Repaci S, et al. New-onset hyperglycemia and acute coronary syndrome: a systematic overview and meta-analysis. Curr Diabetes Rev. 2010;6(2):102-110.

  25. Noordzij PG, Boersma E, Schreiner F, Kertai MD, Feringan HH, Dunkelgrun M, et al. Increased preoperative glucose levels are associated with perioperative mortality in patients undergoing noncardiac, nonvascular surgery. Eur J Endocrinol. 2007;156(1):137-42. Texto libre en http://eje-online.org/content/156/1/137. long

  26. Pomposelli JJ, Baxter JK 3rd, Babineau TJ, Pomfret EA, Driscoll DF, Forse RA, et al. Early postoperative 199 Gracia-Ramos AE. Manejo de la hiperglucemia en hospitalizados Rev Med Inst Mex Seguro Soc. 2015;53(2):192-9 glucose control predicts nosocomial infection rate in diabetic patients. JPEN J Parenter Enteral Nutr. 1998;22(2):77-81.

  27. Dungan KM, Braithwaite SS, Preiser JC. Stress hyperglycaemia. Lancet 2009;373(9677):1798-1807. Texto libre en http://www.ncbi.nlm.nih.gov/pmc/ articles/PMC3144755/

  28. McDonnell ME, Umpierrez GE. Insulin therapy for the management of hyperglycemia in hospitalized patients. Endocrinol Metab Clin North Am. 2012;41(1):175-201. Texto libre en http://www.ncbi. nlm.nih.gov/pmc/articles/PMC3738170/

  29. Umpierrez GE, Hellman R, Korytkowski MT, Kosiborod M, Maynard GA, Montori VM, et al. Management of hyperglucemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2012;97(1):16-38.

  30. American Diabetes Association. Standards or Mmedical Ccare in Ddiabetes – 2014. Diabetes cCare. 2014;37(sSuppl 1):S14-S80.

  31. Mikhail N. Management of hyperglycemia in hospitalized noncritical patients. South Med J. 2013;106(3):238-244.

  32. Murad MH, Coburn JA, Coto-Yglesias F, Dsyubak S, Hazem A, Lane MA, eta al. Glycemic control in non-critically ill hospitalized patients: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2012;97(1):49-58.

  33. Hawkins K, Donihi AC, Korytkowski MT. Glycemic management in medical and surgical patients in non- ICU setting. Curr Diab Rep 2013;13(1):96-106.

  34. Umpierrez GE, Smiley D, Jacobs S, Peng L, Temponi A, Mulligan P, et al. Randomized study of Basalbolus Iinsulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 Surgery). Diabetes Care. 2011;34(2):256-261. Texto libre en http://www.ncbi. nlm.nih.gov/pmc/articles/PMC3024330/

  35. Bogun M, Inzucchi SE. Inpatient management of diabetes and hyperglycemia. Clin Ther. 2013;35(5):724 -733.

  36. Umpierrez GE, Korytkowski M. Is incretin-based therapy ready for the care of hospitalized patients with tipe 2 diabetes? Insulin therapy has proven itself and is considered the mainstay of treatment. Diabetes Care. 2013;36(7):2112-2117. Texto libre en http:// www.ncbi.nlm.nih.gov/pmc/articles/PMC3687276/

  37. Schwartz S, DeFronzo RA. Is incretin-based therapy ready for the care of hospitalized patients with type 2 diabetes? The time has come for GLP-1 receptor agonist!. Diabetes Care. 2013;36(7):2107-2111. Texto libre en http://www.ncbi.nlm.nih.gov/pmc/articles/ PMC3687277/

  38. Umpierrez GE, Smiley D, Zisman A, Prieto LM, Palacio A, Ceron M, et al. Randomized study of basalbolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care. 2007;30(9):2181-2186.

  39. Umpierrez GE, Hor T, Smiley D, Temponi A, Umpierrez D, Ceron M, et al. Comparison of inpatient insulin regimens with determir plus aspart versus neutral protamine hagedorn plus regular in medical patients with type 2 diabetes. J Clin Endocrinol Metab. 2009;94(2):564-569. Texto libre en http://www.ncbi. nlm.nih.gov/pmc/articles/PMC2646523/

  40. Umpierrez GE, Smiley D, Hermayer K, Khan A, Olson DE, Newton C, et al. Randomized study comparing a basal bolus with a basal plus correction insulin regimen for the hospital management of medical and surgical patients with type 2 diabetes: basal plus trial. Diabetes Care. 2013;36(8):2169-2174. Texto libre en http://www.ncbi.nlm.nih.gov/pmc/articles/ PMC3714500/




2020     |     www.medigraphic.com